CFO’s Latest Share Flip at Rapid Micro Biosystems: A Routine Tax‑Cover Sale or Signal of Deeper Liquidity Strategy?
Rapid Micro Biosystems insider sale: CFO’s 5,403-share sell shows routine tax‑cover activity, not a market shift, but signals liquidity strategy for small‑cap biotech investors.
3 minutes to read


